Wu Tiantian, Wang Qiang, Pu Changsheng, Zhang Keming
Department of Hepatobiliary Surgery, Peking University International Hospital, Beijing 100001, China.
Biomedicines. 2023 Oct 19;11(10):2840. doi: 10.3390/biomedicines11102840.
This study aimed to analyze the correlation between islet β cell function and gallbladder stone (GBS) in newly diagnosed type 2 diabetes mellitus (T2DM) patients.
A total of 438 newly diagnosed T2DM patients in Peking University International Hospital from January 2017 to August 2022 were retrospectively analyzed and divided into a non-GBS group and a GBS group.
(1) The homeostasis model assessment of the insulin resistance (HOMA-IR) of the GBS group was higher than that of the non-GBS group ( < 0.05), while the homeostasis model assessment of β cell (HOMA-β), disposition index (DI0), and Matsuda index of the GBS group were lower than those of the non-GBS group (all < 0.05). (2) For male patients, HOMA-IR is an independent risk factor for GBS (OR = 2.00, 95% CI:1.03, 3.88, < 0.05), and the Matsuda index value is a protective factor for GBS (OR = 0.76, 95% CI:0.60, 0.96, < 0.05). For female patients, HOMA-IR is an independent risk factor for GBS (OR = 2.80, 95% CI:1.03, 7.58, < 0.05) and the Matsuda index value is a protective factor for GBS (OR = 0.59, 95% CI:0.39, 0.90, < 0.05). (3) For male patients, the area under curve (AUC) for predicting GBS was 0.77 (95% CI 0.67, 0.87), with a specificity of 75.26%, a sensitivity of 80.00%, and an accuracy of 75.64%. For female patients, the AUC for predicting GBS was 0.77 (95% CI 0.63, 0.88), with a specificity of 79.63%, a sensitivity of 71.43%, and an accuracy of 78.69%.
Insulin resistance may be an independent risk factor for the incidence of GBS in patients with newly diagnosed T2DM, both male or female, which provides a new clinical basis and research direction for the prevention and treatment of GBS in patients with T2DM. This study has established a predictive model of GBS in T2DM and found it to be accurate, thus representing an effective tool for the early prediction of GBS in patients with T2DM.
本研究旨在分析新诊断2型糖尿病(T2DM)患者胰岛β细胞功能与胆囊结石(GBS)之间的相关性。
回顾性分析2017年1月至2022年8月北京大学国际医院438例新诊断的T2DM患者,并将其分为非GBS组和GBS组。
(1)GBS组胰岛素抵抗的稳态模型评估(HOMA-IR)高于非GBS组(<0.05),而GBS组β细胞稳态模型评估(HOMA-β)、处置指数(DI0)和松田指数低于非GBS组(均<0.05)。(2)对于男性患者,HOMA-IR是GBS的独立危险因素(OR = 2.00,95%CI:1.03,3.88,<0.05),松田指数值是GBS的保护因素(OR = 0.76,95%CI:0.60,0.96,<0.05)。对于女性患者,HOMA-IR是GBS的独立危险因素(OR = 2.80,95%CI:1.03,7.58,<0.05),松田指数值是GBS的保护因素(OR = 0.59,95%CI:0.39,0.90,<0.05)。(3)对于男性患者,预测GBS的曲线下面积(AUC)为0.77(95%CI 0.67,0.87),特异性为75.26%,敏感性为80.00%,准确性为75.64%。对于女性患者,预测GBS的AUC为0.77(95%CI 0.63,0.88),特异性为79.63%,敏感性为71.43%,准确性为78.69%。
胰岛素抵抗可能是新诊断T2DM患者发生GBS的独立危险因素,无论男性还是女性,这为T2DM患者GBS的防治提供了新的临床依据和研究方向。本研究建立了T2DM患者GBS的预测模型,发现其具有准确性,是早期预测T2DM患者GBS的有效工具。